David M. Reboussin

17.5k total citations · 5 hit papers
138 papers, 9.6k citations indexed

About

David M. Reboussin is a scholar working on Genetics, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, David M. Reboussin has authored 138 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 24 papers in Cardiology and Cardiovascular Medicine and 24 papers in Hematology. Recurrent topics in David M. Reboussin's work include Iron Metabolism and Disorders (23 papers), Hemoglobinopathies and Related Disorders (22 papers) and Blood Pressure and Hypertension Studies (13 papers). David M. Reboussin is often cited by papers focused on Iron Metabolism and Disorders (23 papers), Hemoglobinopathies and Related Disorders (22 papers) and Blood Pressure and Hypertension Studies (13 papers). David M. Reboussin collaborates with scholars based in United States, Canada and Chile. David M. Reboussin's co-authors include Steven R. Feldman, Stephen R. Rapp, Alan B. Fleischer, M. Lyn Exum, David M. Herrington, Curt D. Furberg, Stephanie S. Daniel, David B. Goldston, William R. Brown and David L. DeMets and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

David M. Reboussin

133 papers receiving 9.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Psoriasis causes as much disability as other major medical diseases

1999 1.2k citations Stephen R. Rapp, David M. Reboussin et al. profile →
Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis

2000 914 citations David M. Reboussin et al. profile →
Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population

2005 547 citations Paul C. Adams, David M. Reboussin et al. profile →
Fundamentals of Clinical Trials

2015 455 citations David M. Reboussin et al. profile →
The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT)

2014 360 citations Walter T. Ambrosius, Alfred K. Cheung et al. profile →

Peers

Countries citing papers authored by David M. Reboussin

Since Specialization

Citations

This map shows the geographic impact of David M. Reboussin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Reboussin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Reboussin more than expected).

Fields of papers citing papers by David M. Reboussin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Reboussin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Reboussin. The network helps show where David M. Reboussin may publish in the future.

Co-authorship network of co-authors of David M. Reboussin

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Reboussin. A scholar is included among the top collaborators of David M. Reboussin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Reboussin. David M. Reboussin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of Daily Avocado Intake on Cardiovascular Health Assessed by Life's Essential 8: An Ancillary Study of HAT, a Randomized Controlled Trial 2025 ·Journal of the American Heart Association ·(unknown), Penny M. Kris‐Etherton, Alice H. Lichtenstein, Nirupa R. Matthan, Joan Sabaté, Zhaoping Li, David M. Reboussin, Kristina Petersen	1
2	Long-Term Effect of Intensive vs Standard Blood Pressure Control on Mild Cognitive Impairment and Probable Dementia in SPRINT 2025 ·Neurology ·David M. Reboussin, Sarah A. Gaussoin, Nicholas M. Pajewski, Byron C. Jaeger, Bonnie C. Sachs, Stephen R. Rapp, Mark A. Supiano, Maryjo Cleveland, (unknown), Jamehl L. Demons, Paula Ogrocki, Alan J. Lerner, Gordon J. Chelune, Virginia G. Wadley, (unknown), Nancy Woolard, Letitia Perdue, Kathryn E. Callahan, Jeff D. Williamson	2
3	Impact of daily avocado consumption on gut microbiota in adults with abdominal obesity: an ancillary study of HAT, a randomized controlled trial 2024 ·Food & Function ·Jieping Yang, (unknown), Shrikant S. Bhute, (unknown), Alice H. Lichtenstein, Nirupa R. Matthan, Kristina Petersen, Joan Sabaté, David M. Reboussin, Laura Lovato, Mara Z. Vitolins, Sujatha Rajaram, Jonathan P. Jacobs, Jianjun Huang, (unknown), (unknown), Zhaoping Li	2
4	Exploratory Analysis of Daily Avocado Consumption for 6-Months on Serum Metabolomic Profiles in Adults With Abdominal Obesity: Habitual Diet and Avocado Trial (HAT) 2024 ·Current Developments in Nutrition ·Nirupa R. Matthan, (unknown), (unknown), Kristina Petersen, Penny M. Kris‐Etherton, Joan Sabaté, Sujatha Rajaram, Zhaoping Li, David M. Reboussin, Alice H. Lichtenstein	0
5	SPRINT Revisited: Updated Results and Implications 2021 ·Hypertension ·Jackson T. Wright, Paul K. Whelton, Karen Johnson, Joni K. Snyder, David M. Reboussin, William C. Cushman, Jeff D. Williamson, Nicholas M. Pajewski, Alfred K. Cheung, Cora E. Lewis, Suzanne Oparil, Michael V. Rocco, Srinivasan Beddhu, Lawrence J. Fine, Jeffrey A. Cutler, Walter T. Ambrosius, Mahboob Rahman, Carolyn H. Still, Zhengyi Chen, Curtis Tatsuoka	16
6	Effects of Weight Loss on Obstructive Sleep Apnea Severity. Ten-Year Results of the Sleep AHEAD Study 2020 ·American Journal of Respiratory and Critical Care Medicine ·Samuel T. Kuna, David M. Reboussin, Elsa S. Strotmeyer, Richard P. Millman, Gary Zammit, Michael P. Walkup, Thomas A. Wadden, Rena R. Wing, F. Xavier Pi‐Sunyer, Adam P. Spira, Gary D. Foster	77
7	Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults 2017 ·Journal of the American College of Cardiology ·David M. Reboussin, Norrina B. Allen, Michael Griswold, Eliseo Güallar, Yuling Hong, Daniel T. Lackland, Edgar R. Miller, Tamar S. Polonsky, Angela M. Thompson‐Paul, Suma Vupputuri	170
8	The Effect of Changes in Cardiorespiratory Fitness and Weight on Obstructive Sleep Apnea Severity in Overweight Adults with Type 2 Diabetes 2016 ·SLEEP ·Christopher E. Kline, David M. Reboussin, Gary D. Foster, Thomas B. Rice, Elsa S. Strotmeyer, John M. Jakicic, Richard P. Millman, F. Xavier Pi‐Sunyer, Anne B. Newman, Thomas A. Wadden, Gary Zammit, Samuel T. Kuna	17
9	The Relationship Between Obstructive Sleep Apnea and Self-Reported Stroke or Coronary Heart Disease in Overweight and Obese Adults with Type 2 Diabetes Mellitus 2012 ·SLEEP ·Thomas B. Rice, Gary D. Foster, Matthew R. Sanders, Mark L. Unruh, David M. Reboussin, Samuel T. Kuna, Richard P. Millman, Gary Zammit, Rena R. Wing, Thomas A. Wadden, David E. Kelley, Xavier Pi‐Sunyer, Anne B. Newman	42
10	A 1-Year Lifestyle Intervention for Weight Loss in Individuals With Type 2 Diabetes Reduces High C-Reactive Protein Levels and Identifies Metabolic Predictors of Change 2010 ·Diabetes Care ·L. Maria Belalcazar, David M. Reboussin, Steven M. Haffner, Ron C. Hoogeveen, Andrea M. Kriska, Dawn C. Schwenke, Russell P. Tracy, F. Xavier Pi‐Sunyer, Christie M. Ballantyne	84
11	Potential Nonresponse Bias in a Clinical Examination After Initial Screening Using Iron Phenotyping and HFE Genotyping in the Hemochromatosis and Iron Overload Screening Study 2009 ·Genetic Testing and Molecular Biomarkers ·Mark Speechley, James C. Barton, Leah Passmore, Helen Harrison, David M. Reboussin, Emily Harris, Charles Rivers, (unknown), Lari Wenzel, (unknown)	0
12	Obesity and Albuminuria Among Adults With Type 2 Diabetes 2009 ·Diabetes Care ·Holly Kramer, David M. Reboussin, Alain G. Bertoni, Santica Marcovina, Edward W. Lipkin, Frank L. Greenway, Frederick L. Brancati	53
13	HFE C282Y Homozygotes Aged 25–29 Years at HEIRS Study Initial Screening 2007 ·PubMed ·James C. Barton, Ronald T. Acton, Catherine Leiendecker‐Foster, Laura Lovato, Paul C. Adams, Gordon D. McLaren, John H. Eckfeldt, Christine E. McLaren, David M. Reboussin, Victor R. Gordeuk, Mark Speechley, Jacob A. Reiss, Richard D. Press, Fitzroy W. Dawkins	6
14	Liver Diseases in the Hemochromatosis and Iron Overload Screening Study 2006 ·Clinical Gastroenterology and Hepatology ·Paul C. Adams, Leah Passmore, Subrata Chakrabarti, David M. Reboussin, Ronald T. Acton, James C. Barton, Gordon D. McLaren, John H. Eckfeldt, Fitzroy W. Dawkins, Victor R. Gordeuk, Emily Harris, Catherine Leiendecker‐Foster, (unknown), Phyliss Sholinsky	43
15	Initial Screening Transferrin Saturation Values, Serum Ferritin Concentrations, and HFE Genotypes in Whites and Blacks in the Hemochromatosis and Iron Overload Screening Study 2005 ·Genetic Testing ·James C. Barton, Ronald T. Acton, Fitzroy W. Dawkins, Paul C. Adams, Laura Lovato, C Leiendecker‐Foster, Christine E. McLaren, David M. Reboussin, Mark Speechley, Victor R. Gordeuk, Gordon D. McLaren, Phyliss Sholinsky, Emily Harris	59
16	Cerebral Microvascular Alterations in Aging, Leukoaraiosis, and Alzheimer's Disease^a 1997 ·Annals of the New York Academy of Sciences ·Dixon M. Moody, William R. Brown, Venkata R. Challa, H. Simon Ghazi-Birry, David M. Reboussin	134
17	Exact permutation inference for two sample repeated measures data 1996 ·Communication in Statistics- Theory and Methods ·David M. Reboussin, David L. DeMets	7
18	The Demand for Episodes of Medical Treatment in the Health Insurance Experiment 1988 ·RAND Corporation eBooks ·Emmett B. Keeler, Joan L. Buchanan, John E. Rolph, Janet Hanley, David M. Reboussin	33
19	Use of medical care in the Rand Health Insurance Experiment. Diagnosis- and service-specific analyses in a randomized controlled trial. 1986 ·PubMed ·Kathleen N Lohr, Robert H. Brook, Caren Kamberg, George A. Goldberg, Arleen Leibowitz, Joan Keesey, David M. Reboussin, Joseph P. Newhouse	255
20	Charges and Outcomes for Rehabilitative Care 1986 ·Susan D. Hosek, Robert L Kane, Maureen F. Carney, (unknown), David M. Reboussin, (unknown), John L. Melvin	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact